BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Abbott Laboratories Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis

  June 5, 2012

   · 

  2 min read
• Business

  Abbott Laboratories Fills Out Leadership Team for Pharma Spinoff AbbVie

  June 5, 2012

   · 

  1 min read
• Lone Star Bio

  Novo Nordisk to Award $80,000 to Local Programs That Help People Living With Diabetes in Houston as Part of Educational Initiative

  June 5, 2012

   · 

  2 min read
• Genetown

  EquipNet Celebrates 13 Years in Business by Expanding Appraisal and Valuation Services

  June 5, 2012

   · 

  7 min read
• Drug Development

  Interim Results from Neovacs SA’ Phase II Clinical Trial in Crohn’s Disease

  June 5, 2012

   · 

  3 min read
• Caris Life Sciences Target Now(TM) American Society of Clinical Oncology Presentations Underscore Importance of Molecular Profiling in Pancreatic Cancer and Uveal Melanoma

  June 5, 2012

   · 

  5 min read
• Drug Development

  AFFiRiS AG Release: Parkinson’s Vaccine - Worldwide First Clinical Study in Vienna

  June 5, 2012

   · 

  3 min read
• Policy

  ISPE Releases New Guidance for Pharmaceutical Change Management as Part of Product Quality Lifecycle Implementation Series

  June 5, 2012

   · 

  1 min read
• Biotech Bay

  After Capturing the U.S. Market, Frost & Sullivan Recognizes Naviscan, Inc.'s Pioneering Organ-Specific PET Scanner’s Potential in Europe

  June 5, 2012

   · 

  5 min read
• BioMidwest

  Roche Diagnostics Corporation Enters Strategic Alliance With Med Fusion That Recognizes Company as a Roche Molecular Center of Excellence

  June 5, 2012

   · 

  3 min read